Strive Health, the national leader in value-based kidney care, and Outset Medical, a dialysis technology innovator, announced a collaboration to help further the companies’ efforts to change the kidney care paradigm. A rapidly growing organization focused on slowing kidney disease progression and preventing costly hospitalizations through a proprietary whole-patient solution, Strive Health will use Outset’s Tablo Hemodialysis System to expand patient access to home hemodialysis.
“The current standard of care for people living with kidney disease falls short for most patients. We’ve set out on a mission to change that through predictive analytics, high-quality, compassionate care and partnerships with other forward-thinking technology companies,” said Chris Riopelle, CEO of Strive Health. “Kidney disease patients deserve access to better, intuitive technology. Solutions like Tablo will help us deliver on a differentiated patient experience.”
Designed for total care of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in a value-based setting, Strive upends the traditional model for kidney care by combining predictive analytics with high-touch, compassionate care teams. Strive recently launched a dialysis facility in Owensboro, KY, focused on patient-centric holistic kidney disease management and home dialysis using Tablo.
“As a leader in whole-patient care, Strive shares our commitment to meeting the patient where they are, and empowering them with actionable data and support along the way,” said Leslie Trigg, CEO of Outset Medical. “Strive is a progressive thinker in the space. This sales agreement is intended to deliver on a shared vision of enabling more patients to enjoy the flexibility, convenience and clinical benefits of home dialysis.”
To learn more about Outset Medical and the Tablo Hemodialysis System, please visit: https://www.outsetmedical.com/.
For more information about Strive Health, please visit: https://www.strivehealth.com/.
Source: Strive Health & Outset Medical